![Albert Dyrness](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Dyrness
Gründer bei
ADVENT Engineering Services, Inc.
Vermögen: 8 811 $ am 31.05.2026
Profil
Albert D.
Dyrness is the founder of ADVENT Engineering Services, Inc., founded in 1988, serving as Managing Director & Vice President.
Current jobs include Vice Chairman-Bioprocess Equipment Standard at American Society of Mechanical Engineers, Director at Sonnet BioTherapeutics, Inc. since 2019, and Independent Director at Hyperliquid Strategies, Inc. starting in 2025.
Former jobs include Independent Director at Outlook Therapeutics, Inc. from 2015 to 2017 and Independent Director at Sonnet BioTherapeutics Holdings, Inc. from 2020 to 2025.
Education includes an undergraduate degree from Massachusetts Institute of Technology, conferred in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0 % | 09.02.2026 | 882 ( 0 % ) | 8 811 $ | 31.05.2026 |
Aktive Positionen von Albert Dyrness
| Unternehmen | Position | Beginn |
|---|---|---|
American Society of Mechanical Engineers
 American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services Operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community | Corporate Officer/Principal | - |
ADVENT Engineering Services, Inc.
 ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Provides superior nuclear power, research and specialty engineering services. | Gründer | 01.01.1988 |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Direktor/Vorstandsmitglied | 01.10.2019 |
Ehemalige bekannte Positionen von Albert Dyrness
| Unternehmen | Position | Ende |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Direktor/Vorstandsmitglied | 02.12.2025 |
| OUTLOOK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2017 |
Ausbildung von Albert Dyrness
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
American Society of Mechanical Engineers
American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services Operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community | Commercial Services |
ADVENT Engineering Services, Inc.
ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Provides superior nuclear power, research and specialty engineering services. | Industrial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
 Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Wählen Sie MarketScreener 
